Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab + Pemetrexed + Carboplatin in Malignant Pleural Mesothelioma
NCT00407459Phase 2Completed
- Sponsor
- Armando Santoro
- Start
- Sep 2007
- Primary completion
- Nov 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in malignant pleural mesothelioma (MPM), sponsored by Armando Santoro. Started Sep 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT00407459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00407459.